Have a feature idea you'd love to see implemented?
Let us know!
OM Outset Medical Inc
Price (delayed)
$0.5502
Market cap
$28.66M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.13
Enterprise value
$189.77M
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to
Highlights
OM's gross margin has surged by 53% year-on-year and by 15% since the previous quarter
OM's gross profit is up by 38% year-on-year and by 7% since the previous quarter
OM's debt has soared by 96% YoY
The equity has plunged by 63% YoY and by 26% from the previous quarter
Key stats
What are the main financial stats of OM
Market
Valuations
Earnings
Shares outstanding
52.09M
Market cap
$28.66M
Enterprise value
$189.77M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.41
Price to sales (P/S)
0.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.63
Revenue
$116.43M
EBIT
-$140.06M
EBITDA
-$132.85M
Free cash flow
-$140M
Per share
Balance sheet
Liquidity
EPS
-$3.13
Free cash flow per share
-$2.7
Book value per share
$1.33
Revenue per share
$2.24
TBVPS
$6.06
Total assets
$314.53M
Total liabilities
$245.94M
Debt
$202.3M
Equity
$68.6M
Working capital
$251.7M
Debt to equity
2.95
Current ratio
6.8
Quick ratio
5.35
Net debt/EBITDA
-1.21
Margins
Efficiency
Dividend
EBITDA margin
-114.1%
Gross margin
28.2%
Net margin
-136.7%
Operating margin
-129.3%
Return on assets
-49.7%
Return on equity
-145.8%
Return on invested capital
-36.5%
Return on capital employed
-51.7%
Return on sales
-120.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OM stock price
How has the Outset Medical stock price performed over time
Intraday
-0.33%
1 week
3.81%
1 month
-18.73%
1 year
-82.08%
YTD
-89.83%
QTD
-18.73%
Financial performance
How have Outset Medical's revenue and profit performed over time
Revenue
$116.43M
Gross profit
$32.87M
Operating income
-$150.48M
Net income
-$159.18M
Gross margin
28.2%
Net margin
-136.7%
OM's gross margin has surged by 53% year-on-year and by 15% since the previous quarter
OM's gross profit is up by 38% year-on-year and by 7% since the previous quarter
Outset Medical's revenue has decreased by 10% YoY and by 7% from the previous quarter
Outset Medical's operating income has increased by 10% YoY and by 8% QoQ
Growth
What is Outset Medical's growth rate over time
Valuation
What is Outset Medical stock price valuation
P/E
N/A
P/B
0.41
P/S
0.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.63
OM's EPS is up by 10% year-on-year and by 7% since the previous quarter
OM's price to book (P/B) is 91% lower than its 5-year quarterly average of 4.6 and 84% lower than its last 4 quarters average of 2.5
The equity has plunged by 63% YoY and by 26% from the previous quarter
OM's price to sales (P/S) is 98% lower than its 5-year quarterly average of 13.3 and 89% lower than its last 4 quarters average of 2.2
Outset Medical's revenue has decreased by 10% YoY and by 7% from the previous quarter
Efficiency
How efficient is Outset Medical business performance
Outset Medical's ROE has plunged by 98% YoY and by 19% from the previous quarter
The return on invested capital has increased by 23% year-on-year and by 13% since the previous quarter
Outset Medical's return on assets has decreased by 7% YoY but it has increased by 4.1% QoQ
OM's return on sales is up by 3.5% year-on-year
Dividends
What is OM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OM.
Financial health
How did Outset Medical financials performed over time
The total assets is 28% greater than the total liabilities
The total liabilities has soared by 63% year-on-year but it has declined by 2.8% since the previous quarter
The total assets has declined by 9% since the previous quarter and by 6% year-on-year
OM's debt is 195% more than its equity
OM's debt has soared by 96% YoY
The equity has plunged by 63% YoY and by 26% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.